Effect of Vitamin D Supplementation on Faecal Microbiota: A Randomised Clinical Trial.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
27 Nov 2019
Historique:
received: 20 10 2019
revised: 20 11 2019
accepted: 25 11 2019
entrez: 1 12 2019
pubmed: 1 12 2019
medline: 12 5 2020
Statut: epublish

Résumé

In animal studies, vitamin D supplementation has been shown to improve gut microbiota and intestinal inflammation. However, limited evidence exists on the effect of vitamin D supplementation on the human gut microbiota. We examined the effect of vitamin D supplementation on faecal microbiota in 26 vitamin D-deficient (25-hydroxyvitamin D (25(OH)D) ≤50 nmol/L), overweight or obese (BMI ≥25 kg/m

Identifiants

pubmed: 31783602
pii: nu11122888
doi: 10.3390/nu11122888
pmc: PMC6950585
pii:
doi:

Substances chimiques

Placebos 0
RNA, Bacterial 0
RNA, Ribosomal, 16S 0
Vitamin D 1406-16-2
Cholecalciferol 1C6V77QF41
25-hydroxyvitamin D A288AR3C9H

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Références

Diabetes. 2008 Jun;57(6):1470-81
pubmed: 18305141
Nat Rev Endocrinol. 2011 Jun;7(6):337-45
pubmed: 21263449
Am J Clin Nutr. 2017 Jun;105(6):1372-1381
pubmed: 28490514
Allergy Asthma Clin Immunol. 2013 Apr 22;9(1):15
pubmed: 23607879
Food Funct. 2015 Feb;6(2):356-62
pubmed: 25367187
Mol Nutr Food Res. 2014 Jul;58(7):1491-501
pubmed: 24823836
Metabolism. 2017 Apr;69:76-86
pubmed: 28285654
J Clin Endocrinol Metab. 2002 Nov;87(11):4952-6
pubmed: 12414856
Diabetes Metab Res Rev. 2012 Jul;28(5):424-30
pubmed: 22344966
United European Gastroenterol J. 2015 Jun;3(3):294-302
pubmed: 26137304
Br J Nutr. 1993 Jan;69(1):233-41
pubmed: 8384476
Inflamm Bowel Dis. 2013 Nov;19(12):2634-43
pubmed: 24105392
Eur J Nutr. 2016 Jun;55(4):1479-89
pubmed: 26130323
Gut Microbes. 2012 May-Jun;3(3):186-202
pubmed: 22572830
PLoS One. 2013 Aug 27;8(8):e71108
pubmed: 24013136
Microb Ecol Health Dis. 2015 Mar 12;26:26914
pubmed: 25769266
Front Immunol. 2016 Dec 23;7:627
pubmed: 28066436
Exp Biol Med (Maywood). 2014 Nov;239(11):1524-30
pubmed: 24668555
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Aliment Pharmacol Ther. 2014 May;39(10):1136-42
pubmed: 24641590
Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):73-83
pubmed: 23768554
Clin Ther. 2015 May 1;37(5):996-1009.e7
pubmed: 26046242
J Investig Med. 2015 Jun;63(5):729-34
pubmed: 25775034
J Nutr. 2013 Oct;143(10):1679-86
pubmed: 23966330
Endocr Rev. 2008 Oct;29(6):726-76
pubmed: 18694980
Genome Med. 2016 Apr 20;8(1):42
pubmed: 27098727
Am J Respir Crit Care Med. 2015 Mar 1;191(5):492-3
pubmed: 25723818
Gut Microbes. 2012 Jul-Aug;3(4):279-88
pubmed: 22572877
Endocr Connect. 2016 Jan;5(1):1-9
pubmed: 26555712
Dig Dis Sci. 2015 Aug;60(8):2427-35
pubmed: 25757449
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Eur J Clin Nutr. 2017 Aug;71(8):931-943
pubmed: 28488684
Rev Endocr Metab Disord. 2017 Jun;18(2):243-258
pubmed: 28409320
Am J Pathol. 2010 Aug;177(2):686-97
pubmed: 20566739
Endocr Pract. 2013 May-Jun;19(3):497-510
pubmed: 23823585
Carcinogenesis. 2001 Sep;22(9):1429-35
pubmed: 11532865
Mol Cell Endocrinol. 2007 Jan 15;263(1-2):55-64
pubmed: 17029768
Am J Physiol Gastrointest Liver Physiol. 2012 Feb 15;302(4):G460-9
pubmed: 22114117
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Mucosal Immunol. 2014 Jul;7(4):983-94
pubmed: 24399150
Ther Adv Endocrinol Metab. 2014 Dec;5(6):166-89
pubmed: 25489472
Trials. 2015 Aug 07;16:335
pubmed: 26246241
FEBS Lett. 2014 Nov 17;588(22):4120-30
pubmed: 24681100
Metabolism. 2014 Sep;63(9):1115-24
pubmed: 25044176
Atherosclerosis. 2013 Mar;227(1):140-6
pubmed: 23298824
Sci Transl Med. 2015 Sep 30;7(307):307ra152
pubmed: 26424567

Auteurs

Negar Naderpoor (N)

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, VIC 3168 Australia.
Diabetes and Vascular Medicine Unit, Monash Health, Clayton, VIC 3168, Australia.

Aya Mousa (A)

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, VIC 3168 Australia.

Luisa Fernanda Gomez Arango (L)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4101, Australia.

Helen L Barrett (HL)

Mater Research Institute, The University of Queensland, South Brisbane, QLD 4101, Australia.
Department of Endocrinology, Mater Health, South Brisbane, QLD 4101, Australia.

Marloes Dekker Nitert (M)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4101, Australia.
Mater Research Institute, The University of Queensland, South Brisbane, QLD 4101, Australia.

Barbora de Courten (B)

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, VIC 3168 Australia.
Diabetes and Vascular Medicine Unit, Monash Health, Clayton, VIC 3168, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH